MiMedx Group Inc (MDXG)
MDXG trades on Nasdaq in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1376339/000137633926000011/0001376339-26-000011-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.
Profile
| Field | Value |
|---|---|
| Ticker | MDXG on Nasdaq |
| Sector | Health Care |
| Industry | Medical/Dental Instruments |
| Country | United States |
| IPO year | Not reported by the screener |
| SEC CIK | 0001376339 |
| SEC industry code | Surgical & Medical Instruments & Apparatus |
| Incorporated in | FLORIDA |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $418.6M |
| Net income | $48.6M |
| Operating income | $63.9M |
| Net margin | 11.6% |
| Operating margin | 15.3% |
| Revenue growth | +20.0% |
| Cash | $166.1M |
| Total assets | $342.7M |
| P/E (computed) | 9.6× |
| P/S (computed) | 1.1× |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | No going-concern finding. | 10-Q 2026-10-28 |
| Cash and burn | $120.8M cash; operating cash flow $5.2M a quarter. | Report 2026-09-30 |
| Shares outstanding | 145,925,591 (2026-10-22); 148,102,159 a year earlier; 116,376,583 three years earlier. | Cover page 2026-10-22 |
| Reverse splits, 3 years | None found | None on EDGAR |
| Shelf and offerings, 12 months | 0 S-3/F-3 shelf filings; 0 424B5 takedowns | None on EDGAR |
| Exchange deficiency notices, 12 months | None | None on EDGAR |
| Auditor | Deloitte & Touche LLP, Atlanta, Georgia, United States | PCAOB Form AP 2026-03-03 |
| Late filings, 12 months | None | None on EDGAR |
| Insider trades, 12 months | Bought $0, sold $433K on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Quarterly results
| Quarter | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| Q3 2026 2026-09-30 | $62.3M | -$8.7M | $3.9M | $120.8M | $0 | $303.7M | 10-Q 2026-10-28 |
| Q2 2026 2026-06-30 | $64.4M | -$14.8M | -$10.0M | $135.8M | $17.2M | $355.2M | 10-Q 2026-07-29 |
| Q1 2026 2026-03-31 | $59.0M | -$10.9M | $1.9M | $159.8M | $17.6M | $389.4M | 10-Q 2026-04-29 |
| Q4 2025 2025-12-31 | $118.1M | $15.2M | $25.0M | $166.1M | $18.0M | $418.6M | 10-K 2026-02-25 |
| Q3 2025 2025-09-30 | $113.7M | $16.7M | $29.3M | $142.1M | $18.2M | $393.4M | 10-Q 2026-10-28 |
| Q2 2025 2025-06-30 | $98.6M | $9.6M | $14.4M | $118.9M | $18.5M | $363.8M | 10-Q 2026-07-29 |
| Q1 2025 2025-03-31 | $88.2M | $7.0M | $5.3M | $106.4M | $18.7M | $352.4M | 10-Q 2026-04-29 |
| Q4 2024 2024-12-31 | $92.9M | $7.4M | $18.8M | $104.4M | $19.0M | $348.9M | 10-K 2026-02-25 |
From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document PROSPECTUS | 424B3 | 2026-09-04 |
| Latest annual report | 10-K | 2026-02-25 |
| Latest quarterly / interim | 10-Q | 2026-10-28 |
| Latest current report | 8-K | 2026-10-28 |
| Latest proxy | DEFA14A | 2026-04-29 |
Source: SEC EDGAR submissions feed, 1,001 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -3.0% |
| 1 month | -31.6% |
| 3 months | -23.6% |
| Year to date | -52.6% |
| 1 year | -57.0% |
| From 52-week high | -56.5% |
Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Medical/Dental Instruments
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| CARL | Carlsmed Inc. | $17.35 | +1.34% | $475.5M |
| RCEL | Avita Medical Inc. | $15.22 | -2.62% | $478.2M |
| MOBI | Mobia Medical Inc. | $13.15 | -0.15% | $438.3M |
| ANGO | AngioDynamics Inc. | $11.78 | -0.76% | $495.4M |
| SI | Shoulder Innovations Inc. | $20.45 | -1.16% | $427.9M |
| BWAY | BrainsWay Ltd. | $9.39 | -7.12% | $376.8M |
| CERS | Cerus Corporation | $1.86 | -6.30% | $375.6M |
| SGHT | Sight Sciences Inc. | $10.59 | -2.22% | $588.6M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier